Top

Published in:

01-09-2014 | Article

Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions

Authors: Linyuan Wang, Cynthia T. Luk, Stephanie A. Schroer, Alannah M. Smith, Xie Li, Erica P. Cai, Herbert Gaisano, Patrick E. MacDonald, Zhenyue Hao, Tak W. Mak, Minna Woo

Published in: Diabetologia | Issue 9/2014

Abstract

Aims/hypothesis

Diabetes mellitus represents a significant burden on the health of the global population. Both type 1 and type 2 diabetes share a common feature of a reduction in functional beta cell mass. A newly discovered ubiquitination molecule HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase (HUWE1 [also known as MULE or ARF-BP1]) is a critical regulator of p53-dependent apoptosis. However, its role in islet homeostasis is not entirely clear.

Methods

We generated mice with pancreas-specific deletion of Huwe1 using a Cre-loxP recombination system driven by the Pdx1 promoter (Pdx1cre ⁺ Huwe1 ^fl/fl) to assess the in vivo role of HUWE1 in the pancreas.

Results

Targeted deletion of Huwe1 in the pancreas preferentially activated p53-mediated beta cell apoptosis, leading to reduced beta cell mass and diminished insulin exocytosis. These defects were aggravated by ageing, with progressive further decline in insulin secretion and glucose homeostasis in older mice. Intriguingly, Huwe1 deletion provided protection against genotoxicity, such that Pdx1cre ⁺ Huwe1 ^fl/fl mice were resistant to multiple-low-dose-streptozotocin-induced beta cell apoptosis and diabetes.

Conclusion/interpretation

HUWE1 expression in the pancreas is essential in determining beta cell mass. Furthermore, HUWE1 demonstrated divergent roles in regulating beta cell apoptosis depending on physiological or genotoxic conditions.

Available only for authorised users

Faideau B, Larger E, Lepault F, Carel JC, Boitard C (2005) Role of beta-cells in type 1 diabetes pathogenesis. Diabetes 54(Suppl 2):S87–S96PubMedCrossRef

DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194PubMedCrossRef

Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581–589PubMedCrossRef

Kruse JP, Gu W (2009) Modes of p53 regulation. Cell 137:609–622PubMedCentralPubMedCrossRef

Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137:413–431PubMedCrossRef

Messmer UK, Ankarcrona M, Nicotera P, Brune B (1994) p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355:23–26PubMedCrossRef

Zhang S, Liu J, Saafi EL, Cooper GJ (1999) Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1/CIP1. FEBS Lett 455:315–320PubMedCrossRef

Gurzov EN, Germano CM, Cunha DA et al (2010) p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic beta-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 285:19910–19920PubMedCentralPubMedCrossRef

Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–S107PubMedCrossRef

10.

Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ (2002) Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 277:49676–49684PubMedCrossRef

11.

Hoshino A, Ariyoshi M, Okawa Y et al (2014) Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic β-cell function in diabetes. Proc Natl Acad Sci U S A 111:3116–3121PubMedCrossRef

12.

Marine JC, Lozano G (2010) Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 17:93–102PubMedCrossRef

13.

Ringshausen I, O'Shea CC, Finch AJ, Swigart LB, Evan GI (2006) Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. Cancer Cell 10:501–514PubMedCrossRef

14.

Dornan D, Wertz I, Shimizu H et al (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429:86–92PubMedCrossRef

15.

Leng RP, Lin Y, Ma W et al (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112:779–791PubMedCrossRef

16.

Chen D, Kon N, Li M, Zhang W, Qin J, Gu W (2005) ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 121:1071–1083PubMedCrossRef

17.

Hao Z, Duncan GS, Su YW et al (2012) The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. J Exp Med 209:173–186PubMedCentralPubMedCrossRef

18.

Adhikary S, Marinoni F, Hock A et al (2005) The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123:409–421PubMedCrossRef

19.

Liu Z, Oughtred R, Wing SS (2005) Characterization of E3Histone, a novel testis ubiquitin protein ligase which ubiquitinates histones. Mol Cell Biol 25:2819–2831PubMedCentralPubMedCrossRef

20.

Zhong Q, Gao W, Du F, Wang X (2005) Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121:1085–1095PubMedCrossRef

21.

Hall JR, Kow E, Nevis KR et al (2007) Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage. Mol Biol Cell 18:3340–3350PubMedCentralPubMedCrossRef

22.

Zhao X, Heng JI, Guardavaccaro D et al (2008) The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat Cell Biol 10:643–653PubMedCentralPubMedCrossRef

23.

Yang T, Buchan HL, Townsend KJ, Craig RW (1996) MCL-1, a member of the BLC-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J Cell Physiol 166:523–536PubMedCrossRef

24.

Rolfo A, Garcia J, Todros T, Post M, Caniggia I (2012) The double life of MULE in preeclamptic and IUGR placentae. Cell Death Dis 3:e305PubMedCentralPubMedCrossRef

25.

Cai EP, Wu X, Schroer SA et al (2013) Retinoblastoma tumor suppressor protein in pancreatic progenitors controls α- and β-cell fate. Proc Natl Acad Sci U S A 110:14723–14728PubMedCentralPubMedCrossRef

26.

Herrera PL (2000) Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 127:2317–2322PubMed

27.

Nguyen KT, Tajmir P, Lin CH et al (2006) Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo. Mol Cell Biol 26:4511–4518PubMedCentralPubMedCrossRef

28.

Wang L, Liu Y, Yan Lu S et al (2010) Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes. Diabetes 59:3117–3126PubMedCentralPubMedCrossRef

29.

Liadis N, Salmena L, Kwan E et al (2007) Distinct in vivo roles of caspase-8 in beta-cells in physiological and diabetes models. Diabetes 56:2302–2311PubMedCrossRef

30.

Choi D, Schroer SA, Lu SY et al (2010) Erythropoietin protects against diabetes through direct effects on pancreatic beta cells. J Exp Med 207:2831–2842PubMedCentralPubMedCrossRef

31.

Le May C, Chu K, Hu M et al (2006) Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A 103:9232–9237PubMedCentralPubMedCrossRef

32.

Tiano JP, Mauvais-Jarvis F (2012) Importance of oestrogen receptors to preserve functional β-cell mass in diabetes. Nat Rev Endocrinol 8:342–351PubMed

33.

Parsons JL, Tait PS, Finch D et al (2009) Ubiquitin ligase ARF-BP1/Mule modulates base excision repair. EMBO J 28:3207–3215PubMedCentralPubMedCrossRef

34.

Kon N, Zhong J, Qiang L, Accili D, Gu W (2012) Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice. J Biol Chem 287:5102–5111PubMedCentralPubMedCrossRef

35.

Choudhury AI, Heffron H, Smith MA et al (2005) The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest 115:940–950PubMedCentralPubMedCrossRef

36.

Gannon M, Shiota C, Postic C, Wright CV, Magnuson M (2000) Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis 26:139–142PubMedCrossRef

37.

Wang L, Opland D, Tsai S et al (2014) Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex. Nat Med 20:484–492

38.

Wicksteed B, Brissova M, Yan W et al (2010) Conditional gene targeting in mouse pancreatic β-cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 59:3090–3098PubMedCentralPubMedCrossRef

39.

Inoue S, Hao Z, Elia AJ et al (2013) Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15. Genes Dev 27:1101–1114PubMedCentralPubMedCrossRef

40.

Warr MR, Mills JR, Nguyen M et al (2011) Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site. J Biol Chem 286:25098–25107PubMedCentralPubMedCrossRef

Title: Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions
Authors: Linyuan Wang
Cynthia T. Luk
Stephanie A. Schroer
Alannah M. Smith
Xie Li
Erica P. Cai
Herbert Gaisano
Patrick E. MacDonald
Zhenyue Hao
Tak W. Mak
Minna Woo
Publication date: 01-09-2014
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 9/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-014-3295-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions

Abstract

Aims/hypothesis

Methods

Results

Conclusion/interpretation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusion/interpretation

Please log in to get access to this content

Other articles of this Issue 9/2014

Association of African genetic ancestry with fasting glucose and HbA1c levels in non-diabetic individuals: the Boston Area Community Health (BACH) Prediabetes Study

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion

Fate of abstracts submitted to the 2004 EASD Annual Meeting in Munich

GAD autoantibody affinity in schoolchildren from the general population

Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page